MedTrace Logo

Executive Function and Symptom Reduction in Youth Receiving Home-based Treatment With Collaborative Problem Solving

NCT04121650 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2023-04-18

No results posted yet for this study

Summary

In this project, the investigators will extend prior results of parent-reported executive function growth and symptom reduction in children receiving home-based treatment with the Collaborative Problem Solving treatment approach (CPS), with a particular focus on examining children who have attention deficit hyperactivity disorder (ADHD). The investigators will examine executive functioning (EF) of children who are receiving CPS, measuring EF with parent-report and objective computer-based tasks, at two timepoints: at the start of treatment and approximately four months later, and will collect symptoms at these plus three additional timepoints: at discharge, 6-months after discharge, and 12-months after discharge.

Conditions

  • Child Behavior
  • Problem Behavior
  • Executive Dysfunction

Interventions

BEHAVIORAL

Collaborative Problem Solving

CPS is an approach for understanding and reducing challenging behavior in youth. Under CPS, caregivers are taught to understand and identify the specific neurocognitive skill deficits that underlie their child's challenging behavior. Then the caregivers are taught to interact with the child in a way that solves chronic behavior problems while building the lagging neurocognitive skills to avoid future problems.

Sponsors & Collaborators

  • Gerstner Philanthropies

    collaborator UNKNOWN

  • Youth Villages

    collaborator OTHER

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Alisha R Pollastri, Ph.D. · Massachusetts General Hospital

Eligibility

Min Age
7 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-14
Primary Completion
2022-07-01
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04121650 on ClinicalTrials.gov